Tsuji, S., Reil K., Nelson K., Proclivo V.H., McGuire K.L., Giacalone, M.J. Intravesical VAX014 synergizes with PD-L1 blockade to enhance local and systemic control of bladder tumors. (2022) Cancer Immunology Research, Vol 10 No.8, 978-995
Hancock, B., McGuire, K., Tsuji, S., Reil, K., Hernandez, V., Giacalone, M., Godbey, WT. A single intravesical instillation of VAX014 inhibits orthotopic superficial bladder tumor implantation to increase survival. (2016) Anticancer Research 36: 6243-6248.
Tsuji, S., Chen, X., Hancock, B., Hernandez, V., Visentin, B., Reil, K., Sabbadini, R., Giacalone, M., Godbey, WT. Pre-clinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer. (2016) Molecular Therapy - Oncolytics, Vol. 3, 16004; doi:10.1038/mto.2016.4
Tsuji, S., Nahli, I., Authement, N., Segall, A., Hernandez, V., Hancock, B., Giacalone, M., Maloy, S. An efficient thermoinducible bacterial suicide system - Elimination of viable parental bacteria from minicells. (2010) BioProcess International, Vol. 8, No. 4, 28-40.
Giacalone M.J., Sabbadini, R.A., Zapata, J.A., Chu Y.L., Berkley, N.L., Salvato M.S., and McGuire, K. Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus. Vaccine,25;12 (2007), 2279-2287.
Giacalone, M. J., S. Pillai, A. L. Chambers, R. A. Sabbadini, K. McGuire. 2006. Immune responses elicited by bacterial minicells capable of simultaneous DNA and protein antigen delivery. Vaccine, 24 (2006), 6009-6017.
Giacalone, M. J., A. M. Gentile, B. T. Lovitt, M. W. Surber, R. A. Sabbadini. 2006. The use of bacterial minicells to transfer plasmid DNA to eukaryotic cells. Cellular Microbiology (2006), 8(10), 1624-1633.
Giacalone, M. J., N. L. Berkley, B. T. Lovitt, A. M. Gentile, C. W. Gunderson and M. W. Surber. Toxic protein expression in Escherichia coli using a rhamnose-based tightly regulated and tunable promoter system. Biotechniques, (2006) 40, 355-364.
Publications
Targeted.
Solutions.
Novel.